Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07515924 · ClinicalTrials.gov registry record · Early Phase 1
Oral Gallium Maltolate for Recurrent Glioblastoma
A Early Phase 1 study, sponsored by Medical College of Wisconsin.
- Not yet
- Registry status
- Early Phase 1
- Development phase
- 8
- Enrollment target
NCT07515924: Clinical Trial Early Phase 1 study, sponsored by Medical College of Wisconsin.
NCT07515924 is a Early Phase 1 study that has not yet begun recruiting, run by Medical College of Wisconsin. The registered enrollment target is 8 participants, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (85% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07515924, a Early Phase 1 study, has not yet begun recruiting, sponsored by Medical College of Wisconsin.
- NOT YET RECRUITING
- Registry status
- Early Phase 1
- Development phase
- 8 participants
- Enrollment target
Study Summary
This is a Phase 0 investigational study to assess the central nervous system penetration and tumoral concentration of gallium in patients with recurrent glioblastoma administered with preoperative gallium maltolate.
Primary Outcome
The difference in gallium concentration between glioma tissue resected from patients treated with gallium maltolate and matched glioma tissue from untreated patients from a tumor bank registry, matched based on age, pathology, and gender. The measure type will be mean reported with standard deviation.
Interventions
- PROCEDURE Surgical Intervention
- DRUG Gallium Maltolate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2026-06 |
| Est. Completion | 2027-09 |
| Phase | Early Phase 1 |
What is known before NCT07515924 opens enrollment
NCT07515924 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 8 participants, a relatively small participant target, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (85% lower).
The record links to 0 conditions, and to 2 interventions - of which Surgical Intervention is the first listed.
NCT07515924 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07515924 about?
NCT07515924 is a clinical study titled "Oral Gallium Maltolate for Recurrent Glioblastoma". This is a Phase 0 investigational study to assess the central nervous system penetration and tumoral concentration of gallium in patients with recurrent glioblastoma administered with preoperative gallium maltolate.
What is the current status of trial NCT07515924?
This trial is currently not yet recruiting. It is a Early Phase 1 study. The enrollment target is 8 participants. The study started on 2026-06. Estimated completion is 2027-09.
What interventions are being tested in trial NCT07515924?
The interventions under investigation include: Surgical Intervention (PROCEDURE), Gallium Maltolate (DRUG).
Who is sponsoring clinical trial NCT07515924?
This trial is sponsored by Medical College of Wisconsin, which has 447 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07515924's enrollment target sits among peer trials
8 1782nd of 2000 higher than 176 of 2,000 other Early Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Early Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia